A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 6,392 shares of VRTX stock, worth $3.16 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
6,392
Previous 6,392 -0.0%
Holding current value
$3.16 Million
Previous $3 Million 0.8%
% of portfolio
0.49%
Previous 0.49%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$407.69 - $446.08 $70,122 - $76,725
172 Added 2.77%
6,392 $2.67 Million
Q4 2022

Jan 18, 2023

SELL
$285.76 - $321.48 $1,428 - $1,607
-5 Reduced 0.08%
6,220 $0
Q1 2022

May 12, 2022

BUY
$221.42 - $260.97 $18,820 - $22,182
85 Added 1.38%
6,225 $1.63 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $1.09 Million - $1.37 Million
6,140 New
6,140 $1.35 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $127B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track J.P. Marvel Investment Advisors, LLC Portfolio

Follow J.P. Marvel Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.P. Marvel Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J.P. Marvel Investment Advisors, LLC with notifications on news.